Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Smooth Muscle | 3 | 2018 | 141 | 1.080 |
Why?
|
| Reactive Oxygen Species | 7 | 2016 | 517 | 0.800 |
Why?
|
| NADPH Oxidases | 4 | 2016 | 85 | 0.770 |
Why?
|
| Resistin | 3 | 2018 | 12 | 0.770 |
Why?
|
| Hypoxia | 9 | 2015 | 681 | 0.760 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2012 | 45 | 0.670 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2017 | 22 | 0.630 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 416 | 0.610 |
Why?
|
| Chemokine CCL11 | 1 | 2016 | 11 | 0.510 |
Why?
|
| Carotid Body | 7 | 2015 | 242 | 0.490 |
Why?
|
| Vascular Calcification | 1 | 2016 | 54 | 0.480 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 243 | 0.470 |
Why?
|
| Inflammation | 2 | 2017 | 1063 | 0.410 |
Why?
|
| Up-Regulation | 4 | 2012 | 740 | 0.390 |
Why?
|
| Hydrogen Sulfide | 4 | 2015 | 54 | 0.380 |
Why?
|
| Protein Kinases | 2 | 2012 | 216 | 0.360 |
Why?
|
| Neuropeptide Y | 2 | 2011 | 31 | 0.360 |
Why?
|
| Aging | 1 | 2016 | 766 | 0.350 |
Why?
|
| Down-Regulation | 2 | 2010 | 526 | 0.340 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 34 | 0.330 |
Why?
|
| Adrenal Medulla | 1 | 2011 | 49 | 0.330 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2010 | 34 | 0.330 |
Why?
|
| Protein Phosphatase 2 | 1 | 2009 | 17 | 0.310 |
Why?
|
| Oxidative Stress | 3 | 2016 | 473 | 0.280 |
Why?
|
| Rats | 11 | 2014 | 4155 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2014 | 1267 | 0.260 |
Why?
|
| Antiporters | 2 | 2006 | 18 | 0.250 |
Why?
|
| Antigens, CD1 | 1 | 2006 | 37 | 0.250 |
Why?
|
| Listeriosis | 1 | 2006 | 90 | 0.240 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 145 | 0.240 |
Why?
|
| Interferon-beta | 1 | 2006 | 126 | 0.240 |
Why?
|
| Immunoglobulins | 2 | 2006 | 144 | 0.240 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2005 | 142 | 0.240 |
Why?
|
| Oxygen | 3 | 2015 | 781 | 0.210 |
Why?
|
| Macrophages | 2 | 2018 | 623 | 0.210 |
Why?
|
| Animals | 18 | 2016 | 28891 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2017 | 3581 | 0.190 |
Why?
|
| Adrenal Cortex | 2 | 2012 | 23 | 0.180 |
Why?
|
| Angiotensin II | 2 | 2012 | 95 | 0.170 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1753 | 0.170 |
Why?
|
| Cystathionine gamma-Lyase | 4 | 2015 | 35 | 0.170 |
Why?
|
| Cell Hypoxia | 2 | 2011 | 187 | 0.160 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 63 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 2 | 2011 | 69 | 0.150 |
Why?
|
| Brain Stem | 2 | 2009 | 170 | 0.140 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2015 | 45 | 0.140 |
Why?
|
| Male | 15 | 2017 | 45865 | 0.140 |
Why?
|
| Antioxidants | 4 | 2013 | 232 | 0.140 |
Why?
|
| Metalloporphyrins | 3 | 2013 | 26 | 0.130 |
Why?
|
| Isoprostanes | 1 | 2016 | 3 | 0.130 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2016 | 12 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 93 | 0.120 |
Why?
|
| Tunica Intima | 1 | 2016 | 61 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2016 | 149 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 161 | 0.120 |
Why?
|
| Endarterectomy, Carotid | 1 | 2016 | 76 | 0.120 |
Why?
|
| Cytokines | 2 | 2017 | 871 | 0.120 |
Why?
|
| Protein Kinase C | 1 | 2016 | 267 | 0.120 |
Why?
|
| Carotid Stenosis | 1 | 2016 | 115 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2016 | 136 | 0.110 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 17 | 0.110 |
Why?
|
| Endothelin-1 | 2 | 2013 | 41 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 3489 | 0.110 |
Why?
|
| Carotid Sinus | 2 | 2011 | 20 | 0.110 |
Why?
|
| Membrane Transport Proteins | 3 | 2006 | 170 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2016 | 244 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2016 | 201 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2013 | 692 | 0.110 |
Why?
|
| Adenosine Triphosphate | 3 | 2011 | 329 | 0.110 |
Why?
|
| Wound Healing | 1 | 2016 | 378 | 0.100 |
Why?
|
| Mice | 6 | 2016 | 12537 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2017 | 267 | 0.100 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 54 | 0.100 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 98 | 0.100 |
Why?
|
| Metalloendopeptidases | 1 | 2013 | 44 | 0.100 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 69 | 0.100 |
Why?
|
| Adenosine Diphosphate | 2 | 2002 | 63 | 0.100 |
Why?
|
| Cell Movement | 1 | 2016 | 816 | 0.090 |
Why?
|
| Aldosterone | 1 | 2012 | 56 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 58 | 0.090 |
Why?
|
| Pressoreceptors | 1 | 2011 | 12 | 0.090 |
Why?
|
| Apoptosis | 1 | 2018 | 1756 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 165 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2015 | 1157 | 0.090 |
Why?
|
| Superior Cervical Ganglion | 1 | 2011 | 3 | 0.090 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 6 | 0.090 |
Why?
|
| Cathepsin L | 1 | 2011 | 7 | 0.090 |
Why?
|
| Carboxypeptidase H | 1 | 2011 | 12 | 0.090 |
Why?
|
| Proprotein Convertase 1 | 1 | 2011 | 11 | 0.090 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 15 | 0.090 |
Why?
|
| Chromaffin Cells | 1 | 2011 | 37 | 0.080 |
Why?
|
| PC12 Cells | 1 | 2010 | 111 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2011 | 73 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 777 | 0.080 |
Why?
|
| Humans | 11 | 2018 | 96108 | 0.070 |
Why?
|
| Hypertension | 1 | 2014 | 774 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2009 | 796 | 0.070 |
Why?
|
| Dopamine | 1 | 2009 | 283 | 0.070 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 106 | 0.070 |
Why?
|
| Antigens, CD1d | 1 | 2006 | 32 | 0.060 |
Why?
|
| HLA-B Antigens | 1 | 2006 | 28 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 139 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1192 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 286 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 445 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 294 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 897 | 0.060 |
Why?
|
| Aged | 3 | 2017 | 20968 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 209 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 810 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 477 | 0.050 |
Why?
|
| Azides | 1 | 2002 | 12 | 0.050 |
Why?
|
| Peptides | 1 | 2006 | 671 | 0.050 |
Why?
|
| Catecholamines | 2 | 2014 | 92 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 829 | 0.050 |
Why?
|
| Respiration | 2 | 2015 | 281 | 0.050 |
Why?
|
| Middle Aged | 3 | 2017 | 28369 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 108 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2939 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 126 | 0.050 |
Why?
|
| Potassium Chloride | 2 | 2012 | 88 | 0.050 |
Why?
|
| Spodoptera | 3 | 2006 | 33 | 0.040 |
Why?
|
| Female | 4 | 2017 | 50030 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 1931 | 0.040 |
Why?
|
| Substance P | 2 | 2011 | 62 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 683 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2002 | 695 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2012 | 656 | 0.040 |
Why?
|
| Calcium | 2 | 2015 | 1205 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2161 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 172 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 62 | 0.030 |
Why?
|
| Protein Binding | 3 | 2006 | 1560 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 299 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2017 | 77 | 0.030 |
Why?
|
| Cell Line | 3 | 2006 | 2537 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 7229 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 64 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 307 | 0.030 |
Why?
|
| Gases | 1 | 2015 | 31 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 123 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 549 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 358 | 0.030 |
Why?
|
| Cysteine | 1 | 2015 | 146 | 0.030 |
Why?
|
| Splanchnic Nerves | 1 | 2014 | 8 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 296 | 0.030 |
Why?
|
| Endothelin-Converting Enzymes | 1 | 2013 | 4 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 469 | 0.030 |
Why?
|
| Time Factors | 2 | 2017 | 5580 | 0.030 |
Why?
|
| Receptor, Endothelin A | 1 | 2013 | 21 | 0.030 |
Why?
|
| Stents | 1 | 2016 | 422 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 253 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1268 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 706 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 611 | 0.020 |
Why?
|
| Cadmium Chloride | 1 | 2012 | 12 | 0.020 |
Why?
|
| Nifedipine | 1 | 2012 | 26 | 0.020 |
Why?
|
| Alkynes | 1 | 2012 | 21 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 460 | 0.020 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2012 | 3 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2012 | 5 | 0.020 |
Why?
|
| Receptors, Angiotensin | 1 | 2012 | 11 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2012 | 27 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2012 | 22 | 0.020 |
Why?
|
| Sulfides | 1 | 2012 | 69 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 707 | 0.020 |
Why?
|
| Glycine | 1 | 2012 | 96 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 122 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2012 | 42 | 0.020 |
Why?
|
| Superoxides | 1 | 2012 | 76 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1805 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2012 | 123 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 21 | 0.020 |
Why?
|
| Time | 1 | 2011 | 79 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 278 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 205 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2011 | 180 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 223 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1010 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2578 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 453 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1828 | 0.020 |
Why?
|
| Amidine-Lyases | 1 | 2008 | 2 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 100 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 622 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1320 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4671 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 926 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2882 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2090 | 0.020 |
Why?
|
| HLA-B44 Antigen | 1 | 2006 | 3 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 1562 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2778 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 5961 | 0.010 |
Why?
|
| Temperature | 1 | 2006 | 426 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 264 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 439 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 750 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 9175 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 145 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 314 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2534 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 564 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 2061 | 0.010 |
Why?
|